CY1110165T1 - Νεες μορφες αλατος μαγνησιου του [r-(r*,r*)]-2-(4-φθοροφαινυλ)-β,β-διυδροξυ-5-(1-μεθυλαιθυλ)-3-5 φαινυλ-4-[(φαινυλαμινο)καρβονυλ]-1η-πυρρολο-1-επτανοϊκου οξεος - Google Patents

Νεες μορφες αλατος μαγνησιου του [r-(r*,r*)]-2-(4-φθοροφαινυλ)-β,β-διυδροξυ-5-(1-μεθυλαιθυλ)-3-5 φαινυλ-4-[(φαινυλαμινο)καρβονυλ]-1η-πυρρολο-1-επτανοϊκου οξεος

Info

Publication number
CY1110165T1
CY1110165T1 CY20101100606T CY101100606T CY1110165T1 CY 1110165 T1 CY1110165 T1 CY 1110165T1 CY 20101100606 T CY20101100606 T CY 20101100606T CY 101100606 T CY101100606 T CY 101100606T CY 1110165 T1 CY1110165 T1 CY 1110165T1
Authority
CY
Cyprus
Prior art keywords
magnesium salt
new forms
finyl
pyrrolo
methylethyl
Prior art date
Application number
CY20101100606T
Other languages
English (en)
Inventor
Jason Albert Leonard
Jonathan Mark Miller
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06809231A external-priority patent/EP1957452B1/en
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of CY1110165T1 publication Critical patent/CY1110165T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Περιγράφονται νέες μορφές άλατος μαγνησίου ατορβαστατίνης που ορίζονται μορφή Α, Μορφή Β, Μορφή C, Μορφή D, Μορφή Ε και Μορφή F, φαρμακευτικές συνθέσεις που περιέχουν τέτοιες ενώσεις, μέθοδοι για την παρασκευή αυτών και μέθοδοι χρήσης των ενώσεων για θεραπεία υπερλιπιδαιμίας, υπερχοληστερολαιμίας, οστεοπόρωσης, καλοήθους προστατικής υπερπλασίας (ΒΡΗ) και ασθένειας Alzheimer.
CY20101100606T 2005-11-21 2010-07-01 Νεες μορφες αλατος μαγνησιου του [r-(r*,r*)]-2-(4-φθοροφαινυλ)-β,β-διυδροξυ-5-(1-μεθυλαιθυλ)-3-5 φαινυλ-4-[(φαινυλαμινο)καρβονυλ]-1η-πυρρολο-1-επτανοϊκου οξεος CY1110165T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73844705P 2005-11-21 2005-11-21
EP06809231A EP1957452B1 (en) 2005-11-21 2006-11-09 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium

Publications (1)

Publication Number Publication Date
CY1110165T1 true CY1110165T1 (el) 2015-01-14

Family

ID=42664731

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100606T CY1110165T1 (el) 2005-11-21 2010-07-01 Νεες μορφες αλατος μαγνησιου του [r-(r*,r*)]-2-(4-φθοροφαινυλ)-β,β-διυδροξυ-5-(1-μεθυλαιθυλ)-3-5 φαινυλ-4-[(φαινυλαμινο)καρβονυλ]-1η-πυρρολο-1-επτανοϊκου οξεος

Country Status (1)

Country Link
CY (1) CY1110165T1 (el)

Similar Documents

Publication Publication Date Title
WO2005105738A3 (en) Salt forms of atorvastatin
GEP20053546B (en) Crystalline Forms of 'R-(R*,R*)!-2-(4- Fluorophenyl)-Beta, Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-'Phenylamino) Carbonyl!-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1) (Atorvastatin)
CL2004000985A1 (es) Compuestos derivados de fenilquinolinas; composicion farmaceutica, proceso de preparacion; y uso para tratar osteoporosis, enfermedad de paget, dano vascular, osteoartritis, cancer oseo, cancer ovarico, cancer prostatico, hipercolesterolemia, aterosc
WO2005065195A3 (en) Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005004803A3 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
BR0116785A (pt) Processo para a sìntese da forma v de atorvastatina e fenilboronatos como compostos intermediários
WO2005004802A3 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
TW200738624A (en) Novel forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium
EP1562897A4 (en) PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
WO2004062625A3 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
MXPA05011536A (es) Acidos carboxilicos substituidos con fenilo como inhibidores de la proteina tirosina fosfatasa-1b.
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
BRPI0518300A2 (pt) derivados de Ácido 7-(2h-pirazol-3-il)-3,5-diidràxi-heptanàico como inibidores da hmg co-a reductase para o tratamento de lipidemia
NO20085338L (no) Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav
EA200702674A1 (ru) Способ лечения атеросклероза, дислипидемий и связанных с ними состояний и фармацевтические композиции
WO2004027075A3 (en) Chemoenzymatic methods for the synthesis of statins and stain intermediates
CY1109045T1 (el) Ρετινοειδη για τη θεραπεια του εμφυσηματος
DK1443967T3 (da) Kombination af cyclooxygenase-2-inhibitor/histondeacetylaseinhibitor
WO2005018545A3 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007058862A3 (en) Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
DE602005007912D1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
DE602006019710D1 (de) Magnesiumsalze von hmg-coa-reduktase-hemmern
MXPA05012955A (es) Composiciones farmaceuticas de atorvastatina.
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit